We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Novel Technology Halves Time for Real-Time PCR

By HospiMedica staff writers
Posted on 02 Feb 2007
A novel technology significantly reduces processing times of the real-time polymerase chain reaction (PCR). More...
It can be used on all real-time instruments.

Quantifast technology is based on fast-cycling PCR. Kits allow customers to reduce the duration of PCR to 40–60 minutes. Users can save more than 50% of the time previously needed, without compromising sensitivity or reproducibility.

The PCR is a one of the most widely used and important technologies in modern molecular biology, which allows the detection of genetic targets in samples. Real-time PCR expands the information available in PCR assays by providing online, real-time quantification of the target genetic material.

Qiagen (Hilden, Germany) has launched the Quantifast line, which significantly increases speed in real-time PCR assays. The kits are compatible with all commercially available real-time PCR instruments, known as thermocyclers, and with existing PCR assays. They can be used with these without requiring complex adaptations (such as new primer design or optimization of PCR protocols). The Quantifast kits enable higher sample throughput using existing laboratory apparatus or established real-time PCR systems. This avoids the need for expensive purchases of faster PCR instruments.

"The unique Quantifast kits broaden Qiagen's already leading portfolio of assay technologies for research, applied testing, and molecular diagnostics and are further evidence of Qiagen's technology leadership”, said Dr. Janina Lehmann, global business director, gene expression at Qiagen. "The innovative Quantifast kits enable users to more than double their throughput without compromising quality, cost, and assay design. These advantages allow our customers fast and immediate access to a new dimension of possibilities in real-time PCR.”

The Quantifast kits can be used for screenings in applied testing, to deliver reliable diagnostic results more rapidly in acute epidemics as a component of a self-validated test system, and to speed up drug development in the pharmaceutical industry.



Related Links:
Qiagen

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Premium Air-Mattress
MA-51
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.